{"filing":{"accession_number":"0001022079-26-000067","cik":"0001022079","ticker":"DGX","company_name":"QUEST DIAGNOSTICS INC","form":"8-K","filing_date":"2026-07-23","report_date":null,"primary_document":"dgx-20260723.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207926000067/dgx-20260723.htm"},"events":[{"id":19777,"run_id":17797,"accession_number":"0001022079-26-000067","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"Quest Diagnostics issued a press release on July 23, 2026 announcing second quarter 2026 financial results, including net revenues of $3.04 billion (up 10.2% YoY), diluted EPS of $2.84 (up 15.0% YoY), and adjusted diluted EPS of $3.12 (up 19.1% YoY). The company also raised full-year 2026 guidance for both revenues and EPS. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 disclosure requirements.","company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":[{"id":18962,"accession_number":"0001022079-26-000067","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Quest Diagnostics issued a press release on July 23, 2026 announcing second quarter 2026 financial results, including net revenues of $3.04 billion (up 10.2% YoY), diluted EPS of $2.84 (up 15.0% YoY), and adjusted diluted EPS of $3.12 (up 19.1% YoY). The company also raised full-year 2026 guidance for both revenues and EPS. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 disclosure requirements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T10:47:37.492574+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18962,"accession_number":"0001022079-26-000067","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Quest Diagnostics issued a press release on July 23, 2026 announcing second quarter 2026 financial results, including net revenues of $3.04 billion (up 10.2% YoY), diluted EPS of $2.84 (up 15.0% YoY), and adjusted diluted EPS of $3.12 (up 19.1% YoY). The company also raised full-year 2026 guidance for both revenues and EPS. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 disclosure requirements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T10:47:37.492574+00:00","company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","filing_date":"2026-07-23"}]}